共 106 条
[1]
Lu Y(2020)Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer Nat. Med. 26 732-740
[2]
Frangoul H(2021)CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia New Engl. J. Med. 384 252-260
[3]
Gillmore JD(2021)CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis New Engl. J. Med. 385 493-502
[4]
Fu Y(2013)High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells Nat. Biotechnol. 31 822-826
[5]
Pattanayak V(2013)High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity Nat. Biotechnol. 31 839-843
[6]
Zhang XH(2015)Off-target effects in CRISPR/Cas9-mediated genome engineering Mol. Ther. Nucleic Acids 4 e264-131
[7]
Tee LY(2015)Therapeutic genome editing: prospects and challenges Nat. Med. 21 121-236
[8]
Wang XG(2020)The promise and challenge of therapeutic genome editing Nature 578 229-191
[9]
Huang QS(2016)Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 Nat. Biotechnol. 34 184-124
[10]
Yang SH(2018)Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells Nat. Commun. 9 111-197